Sangui invents and develops innovative proprietary medical and cosmetic products, and underpins these inventions with patents and testing. It is Sangui s strategy to place the legalization and subsequent marketing and distribution into the hands of competent specialists and to collect revenues mainly from royalties.
Quote | Sangui Biotech Intl Inc (OTCMKTS:SGBI)
Last: | $0.0015 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0015 |
Close: | $0.0015 |
High: | $0.0015 |
Low: | $0.0015 |
Volume: | 200,000 |
Last Trade Date Time: | 01/17/2024 03:00:00 am |
News | Sangui Biotech Intl Inc (OTCMKTS:SGBI)
WITTEN / ACCESSWIRE / March 06, 2019 / The European Patent Office has granted a patent for Sangui's proposed technology/treatment (SBT 102) for septic shock patients, effective March, 6, 2019*. The patent follows up on animal studies carried out by the ECCPS (Excellence Cluster Cardio-Pulmon...
Message Board Posts | Sangui Biotech Intl Inc (OTCMKTS:SGBI)
Subject | By | Source | When |
---|---|---|---|
Nice day here! | nickeli54 | investorshub | 10/04/2021 2:52:36 PM |
PATENT GRANTED: https://www.accesswire.com/538177/Sangui-BioTech-International-I | daytrader868 | investorshub | 03/06/2019 1:19:13 PM |
When is the fda goiing to start the | Gowvu | investorshub | 02/02/2018 6:25:48 AM |
here's some buying coming through.... | gwat1979 | investorshub | 01/02/2018 8:56:13 PM |
The germans did not catch it, yet ? | paulsbest | investorshub | 11/14/2017 2:10:08 PM |
News, Short Squeeze, Breakout and More Instantly...
Sangui Biotech Intl Inc Company Name:
SGBI Stock Symbol:
OTCMKTS Market:
WITTEN / ACCESSWIRE / March 06, 2019 / The European Patent Office has granted a patent for Sangui's proposed technology/treatment (SBT 102) for septic shock patients, effective March, 6, 2019*. The patent follows up on animal studies carried out by the ECCPS (Excellence Cluster Cardio-Pulmon...